HLB Pep Co., Ltd. (KOSDAQ:196300)
3,400.00
-260.00 (-7.10%)
At close: Nov 6, 2026
HLB Pep Market Cap
HLB Pep has a market cap or net worth of 31.88 billion as of November 5, 2026. It is the 34,953rd most valuable company in the world and the 2,034th biggest in South Korea. Its market cap has decreased by 48.42% in one year.
Market Cap
31.88B
Enterprise Value
24.81B
Revenue
5.54B
Global Rank
Country Rank
#2,034 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 2016, HLB Pep's market cap has decreased from 59.66B to 31.88B, a decrease of -46.56%. That is a compound annual growth rate of -6.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 31.88B | -52.09% |
| Dec 30, 2025 | 66.54B | -5.59% |
| Dec 30, 2024 | 70.48B | -19.25% |
| Dec 28, 2023 | 87.28B | 110.23% |
| Dec 29, 2022 | 41.51B | -51.73% |
| Dec 30, 2021 | 86.00B | 24.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KoBioLabs | 51.56B |
| Psomagen | 51.36B |
| Epibiotech | 49.48B |
| ADBiotech | 48.94B |
| QuadMedicine | 46.85B |
| J2KBIO | 46.60B |
| Parataxis Korea | 44.13B |
| Quratis | 40.87B |